zum Inhalt
Header Image

Array Peter LLEWELLYN-DAVIES Chief Executive Officer, APEIRON Biologics AG, Vienna

CV

Education Business Studies, University of London Marketing, St. Galler Business School, St. Gallen Fellowship of the London Institute of Banking and Finance 1996-2003 Managing Director, Süd-Chemie AG, Munich 2003-2005 Executive Director, Müller Dairy UK Ltd. 2006-2012 Chief Financial Officer, Wilex AG, Munich 2012-2016 Chief Financial Officer and Chief Business Officer, Medigene AG, Munich since 2006 Founder and Chief Executive Officer, Accellerate Partners, London and Munich since 2016 Non-Executive Director and Chairman of Audit Committee, Shield Therapeutics PLC, London since 2017 Member of the Supervisory Board and Chairman of Audit Committee, Sygnis AG, Heidelberg since 2017 Chief Financial Officer and Chief Business Officer, APEIRON Biologics AG, Vienna since 2018 Chief Executive Officer, APEIRON Biologics AG, Vienna